Global Radiopharmaceuticals Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Radiopharmaceuticals Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Radiopharmaceuticals Market Size Growth Rate by Product
  • 1.4.2 Diagnostic Radioisotopes
  • 1.4.3 Therapeutic Radioisotopes
• 1.5 Market by End User
  • 1.5.1 Global Radiopharmaceuticals Market Size Growth Rate by End User
  • 1.5.2 Oncology
  • 1.5.3 Cardiology
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Radiopharmaceuticals Market Size
  • 2.1.1 Global Radiopharmaceuticals Revenue 2014-2025
  • 2.1.2 Global Radiopharmaceuticals Sales 2014-2025
• 2.2 Radiopharmaceuticals Growth Rate by Regions
  • 2.2.1 Global Radiopharmaceuticals Sales by Regions
  • 2.2.2 Global Radiopharmaceuticals Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Radiopharmaceuticals Sales by Manufacturers
  • 3.1.1 Radiopharmaceuticals Sales by Manufacturers
  • 3.1.2 Radiopharmaceuticals Sales Market Share by Manufacturers
  • 3.1.3 Global Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
• 3.2 Radiopharmaceuticals Revenue by Manufacturers
  • 3.2.1 Radiopharmaceuticals Revenue by Manufacturers (2014-2019)
  • 3.2.2 Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)
• 3.3 Radiopharmaceuticals Price by Manufacturers
• 3.4 Radiopharmaceuticals Manufacturing Base Distribution, Product Types
  • 3.4.1 Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Radiopharmaceuticals Product Type
  • 3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Radiopharmaceuticals Sales by Product
• 4.2 Global Radiopharmaceuticals Revenue by Product
• 4.3 Radiopharmaceuticals Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Radiopharmaceuticals Breakdown Data by End User

6 North America

• 6.1 North America Radiopharmaceuticals by Countries
  • 6.1.1 North America Radiopharmaceuticals Sales by Countries
  • 6.1.2 North America Radiopharmaceuticals Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Radiopharmaceuticals by Product
• 6.3 North America Radiopharmaceuticals by End User

7 Europe

• 7.1 Europe Radiopharmaceuticals by Countries
  • 7.1.1 Europe Radiopharmaceuticals Sales by Countries
  • 7.1.2 Europe Radiopharmaceuticals Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Radiopharmaceuticals by Product
• 7.3 Europe Radiopharmaceuticals by End User

8 Asia Pacific

• 8.1 Asia Pacific Radiopharmaceuticals by Countries
  • 8.1.1 Asia Pacific Radiopharmaceuticals Sales by Countries
  • 8.1.2 Asia Pacific Radiopharmaceuticals Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Radiopharmaceuticals by Product
• 8.3 Asia Pacific Radiopharmaceuticals by End User

9 Central & South America

• 9.1 Central & South America Radiopharmaceuticals by Countries
  • 9.1.1 Central & South America Radiopharmaceuticals Sales by Countries
  • 9.1.2 Central & South America Radiopharmaceuticals Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Radiopharmaceuticals by Product
• 9.3 Central & South America Radiopharmaceuticals by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Radiopharmaceuticals by Countries
  • 10.1.1 Middle East and Africa Radiopharmaceuticals Sales by Countries
  • 10.1.2 Middle East and Africa Radiopharmaceuticals Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Radiopharmaceuticals by Product
• 10.3 Middle East and Africa Radiopharmaceuticals by End User

11 Company Profiles

• 11.1 Bracco Imaging
  • 11.1.1 Bracco Imaging Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Bracco Imaging Radiopharmaceuticals Products Offered
  • 11.1.5 Bracco Imaging Recent Development
• 11.2 Bayer
  • 11.2.1 Bayer Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Bayer Radiopharmaceuticals Products Offered
  • 11.2.5 Bayer Recent Development
• 11.3 Mallinckrodt
  • 11.3.1 Mallinckrodt Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Mallinckrodt Radiopharmaceuticals Products Offered
  • 11.3.5 Mallinckrodt Recent Development
• 11.4 Nordion
  • 11.4.1 Nordion Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Nordion Radiopharmaceuticals Products Offered
  • 11.4.5 Nordion Recent Development
• 11.5 Triad Isotopes
  • 11.5.1 Triad Isotopes Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Triad Isotopes Radiopharmaceuticals Products Offered
  • 11.5.5 Triad Isotopes Recent Development
• 11.6 Lantheus
  • 11.6.1 Lantheus Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Lantheus Radiopharmaceuticals Products Offered
  • 11.6.5 Lantheus Recent Development
• 11.7 IBA Group
  • 11.7.1 IBA Group Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 IBA Group Radiopharmaceuticals Products Offered
  • 11.7.5 IBA Group Recent Development
• 11.8 GE Healthcare
  • 11.8.1 GE Healthcare Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 GE Healthcare Radiopharmaceuticals Products Offered
  • 11.8.5 GE Healthcare Recent Development
• 11.9 China Isotope & Radiation
  • 11.9.1 China Isotope & Radiation Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 China Isotope & Radiation Radiopharmaceuticals Products Offered
  • 11.9.5 China Isotope & Radiation Recent Development
• 11.10 Jubilant Pharma
  • 11.10.1 Jubilant Pharma Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Jubilant Pharma Radiopharmaceuticals Products Offered
  • 11.10.5 Jubilant Pharma Recent Development
• 11.11 Eli Lilly
• 11.12 Advanced Accelerator Applications
• 11.13 SIEMENS
• 11.14 Dongcheng
• 11.15 Navidea

12 Future Forecast

• 12.1 Radiopharmaceuticals Market Forecast by Regions
  • 12.1.1 Global Radiopharmaceuticals Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Radiopharmaceuticals Revenue Forecast by Regions 2019-2025
• 12.2 Radiopharmaceuticals Market Forecast by Product
  • 12.2.1 Global Radiopharmaceuticals Sales Forecast by Product 2019-2025
  • 12.2.2 Global Radiopharmaceuticals Revenue Forecast by Product 2019-2025
• 12.3 Radiopharmaceuticals Market Forecast by End User
• 12.4 North America Radiopharmaceuticals Forecast
• 12.5 Europe Radiopharmaceuticals Forecast
• 12.6 Asia Pacific Radiopharmaceuticals Forecast
• 12.7 Central & South America Radiopharmaceuticals Forecast
• 12.8 Middle East and Africa Radiopharmaceuticals Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Radiopharmaceuticals Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details